← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Parabon Nanolabs, Inc.
Reston, VA
$8,313,763
Total funding
15
Grants
Funding over time
peak $1.5M · FY2009–24$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,410,474 · 11
NSF$903,289 · 4
By mechanism
R44$4,488,425 · 2
R43$1,474,265 · 5
—$903,289 · 4
R41$630,000 · 2
N43$599,999 · 1
U43$217,785 · 1
Investigators at Parabon Nanolabs, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Smartphone phenotype collection for diagnostic screening of mild cognitive impairment$1,186,625
R44 · FY2021 · AG
Novel whole-genome analysis methods for Alzheimer's risk prediction$917,300
R44 · FY2023 · AG
Smartphone phenotype collection for diagnostic screening of mild cognitive impairment$742,644
R44 · FY2022 · AG
Novel whole-genome analysis methods for Alzheimer's risk prediction$648,343
R44 · FY2024 · AG
SBIR Phase II: Nano-scale Engineering via Grid-scale Computing: Designing, Optimizing and Manufacturing Cancer Therapeutics$603,399
· FY2010 · TIP
DNA Based Nanoparticle Platform for HIV Env Presentation$599,999
N43 · FY2019 · AI
Novel whole-genome analysis methods for Alzheimer's risk prediction$579,228
R44 · FY2018 · AG
Novel whole-genome analysis methods for Alzheimer's risk prediction$414,285
R44 · FY2019 · AG
Smartphone phenotype collection for diagnostic screening of mild cognitive impairment$394,297
R43 · FY2018 · AG
A nanoengineering platform for programmable gene editing therapies against rare diseases$325,000
R43 · FY2023 · GM
Parametric design software for nanostructured CRISPR payloads$299,999
R43 · FY2023 · GM
A multitargeted nanocarrier inhibitor of undruggable transcription factors for treating castration resistant prostate cancer$250,509
R41 · FY2021 · CA
Optimizing Vaccines by Targeting Dendritic Cells with IFNa and IFNb Inducing Adjuvants$230,000
R41 · FY2016 · AI
A DNA nanotechnology vaccine platform for delivery and translation of HIV-1 1086C gp160 Env LNP$225,220
R43 · FY2019 · AI
Novel whole-genome analysis methods for Alzheimer's risk prediction$179,819
R43 · FY2015 · AG
Mixed-Ligand Targeting of a Nano-Pharmaceutical Against GBM Stem Cells$174,766
U43 · FY2011 · CA
SBIR Phase I: A Novel Method for Identifying Synthetic Binding Agents for Targeting Drugs to Specific Tissues$150,000
· FY2014 · TIP
A multitargeted nanocarrier inhibitor of undruggable transcription factors for treating castration resistant prostate cancer$149,491
R41 · FY2022 · CA
SBIR Phase I: Nano-scale Engineering via Grid-scale Computing: Designing, Optimizing and Manufacturing Cancer Therapeutics$99,890
· FY2009 · TIP
SBIR Phase IB: Nano-scale Engineering via Grid-scale Computing: Designing, Optimizing and Manufacturing Cancer Therapeutics$50,000
· FY2010 · TIP